Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 2.02, 9.01 · 8-K

Covista Inc.

Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition On January 28, 2026, Adtalem Global Education Inc. (“Adtalem”) issued a press release announcing its second quarter fiscal 2026 academic, operating and financial results. The press release is attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.…

Filed Jan 28, 2026Accepted Jan 28, 2026, 4:17 PM ESTCIK 730464Accession 0000730464-26-000003
Share

Company context

Covista (NYSE: CVSA) is America's largest healthcare educator, serving 100,000 students and supported by a community of 400,000 alumni across five accredited institutions. Through personalized, tech-enabled education powered by 10,000 faculty and colleagues, Covista expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale. Covista is the parent company of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. For more information, visit covista.com and follow us on LinkedIn, Instagram and YouTube.

Current securities

Historical securities (1)

Recent company filings

  1. 10-Q filingOct 29, 2026
  2. Results of Operations and Financial ConditionOct 29, 2026
  3. DEFA14A filingOct 14, 2026
  4. ARS filingOct 2, 2026
  5. DEFA14A filingOct 2, 2026

Registered securities in this filing

ADTALEM GLOBAL EDUCATION INC. · 8-K · Filed 2026-01-28

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock $0.01 Par Value

Symbol
ATGE
Exchange
NYSE
Classification
COMMON
Status
Historical · closed Feb 23, 2026
Filing context

Context: Duration_1_28_2026_To_1_28_2026_IxI5XScuy06tKzXXSGUizA

Dimensions: Not supplied

Accession 000073046426000003 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition On January 28, 2026, Adtalem Global Education Inc. (“Adtalem”) issued a press release announcing its second quarter fiscal 2026 academic, operating and financial results. The press release is attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information furnished pursuant to this Item 2.02, including Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Adtalem under the Securities Act of 1933, as amended, or the Exchange Act. Cautionary Disclosure Regarding Forward-Looking Statements Certain statements contained in this Form 8-K and related press release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Adtalem’s future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “future,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “may,” “will,” “would,” “could,” “can,” “continue,” “preliminary,” “range,” and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. “Risk Factors” of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and Adtalem assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.
Filed exhibits (1)
EX-99.1 (by filename) atge-20260128xex99d1.htm

EX-99.1 2 atge-20260128xex99d1.htm EX-99.1 Exhibit 99.1 Investor Contact: Jay Spitzer Investor. Relations@Adtalem.com +1 312-906-6600 Media Contact: Maureen Bender AdtalemMedia@Adtalem.com +1 313-319-4732 ADTALEM GLOBAL EDUCATION SECOND QUARTER FISCAL YEAR 2026 RESULTS; RAISES FISCAL YEAR 2026 ADJUSTED EARNINGS PER SHARE GUIDANCE Total enrollment up 6.3% YoY Revenue up 12.4% YoY Diluted earnings per share $2.11; Adjusted EPS $2.43, growth of 34.3% YoY SECOND QUARTER HIGHLIGHTS Total student enrollment 97,010, up 6.3% year-over-year, achieved tenth straight quarter of growth Revenue $503.4 million, up 12.4% year-over-year Walden University achieved tenth straight quarter of total enrollment growth, up 13.0% year-over-year, highest total enrollment in university history Chamberlain University achieved fourteenth straight quarter of pre-licensure BSN total enrollment growth ──────────────────────────────────────────────────────────────────────────────────────────────────────────── Sustaining momentum, GAAP net income $76.4 million; adjusted EBITDA $154.9 million, up 23.9% year-over-year CAPITAL ALLOCATION Completed $150 million May 2025 Board-author…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.